Keyphrases
Breast Cancer
100%
Estrogen Receptor Signaling
100%
Antiestrogen
100%
Antiestrogen Resistance
100%
Estrogen Receptor Status
66%
Acquired Resistance
50%
Estrogen Receptor
33%
Gene Network
33%
Resistance Mechanisms
33%
Estrogenic
33%
Response Predictors
16%
Tumor
16%
Growth Factors
16%
Estrogen
16%
Treatment Choice
16%
Fulvestrant
16%
Mechanism of Action
16%
Proteomic Analysis
16%
Hormone Receptor-positive
16%
Environmental Exposure
16%
Estrogen Therapy
16%
Network Approach
16%
Clinical Response
16%
Corepressor
16%
Transcriptome Analysis
16%
Hormone Replacement Therapy
16%
Resistance Phenotypes
16%
Coactivator
16%
Raloxifene
16%
Unresponsiveness
16%
Dietary Exposure
16%
Invasive Breast Carcinoma
16%
Putative Genes
16%
One-component
16%
Mechanistic Aspects
16%
Resistance Resistance
16%
Functional Redundancy
16%
Nucleophosmin 1 (NPM1)
16%
IRF1
16%
X-box Binding Protein 1 (XBP1)
16%
Ubiquitous Expression
16%
Toremifene
16%
Breast Cancer Chemoprevention
16%
Estrogenic Hormones
16%
Medicine and Dentistry
Breast Cancer
100%
Antiestrogen
100%
Estrogen Receptor
100%
Receptor Expression
33%
Tamoxifen
16%
Neoplasm
8%
Receptor
8%
Chemoprevention
8%
Ras
8%
Cytokine
8%
Absence
8%
Hormone Substitution
8%
Breast Carcinoma
8%
Fulvestrant
8%
Gene Expression Profiling
8%
Environmental Exposure
8%
Nucleophosmin
8%
X Box Binding Protein 1
8%
Interferon Regulatory Factor 1
8%
Proteome Analysis
8%
Toremifene
8%
Growth Factor
8%
Mitogen-Activated Protein Kinase
8%
Hormone Receptor
8%
Raloxifene
8%
Estrogens
8%
Pharmacology, Toxicology and Pharmaceutical Science
Estrogen Receptor
100%
Breast Cancer
100%
Antiestrogen
100%
Tamoxifen
16%
Replacement Therapy
8%
Growth Factor
8%
Raloxifene
8%
Receptor
8%
Fulvestrant
8%
Breast Carcinoma
8%
Cytokine
8%
Environmental Exposure
8%
Absence
8%
Nucleophosmin
8%
Interferon Regulatory Factor 1
8%
X Box Binding Protein 1
8%
Toremifene
8%
Neoplasm
8%
Transcriptome
8%
Hormone Receptor
8%
Estrogens
8%
Neuroscience
Estrogen Receptor
100%
Antiestrogen
100%
Receptor Expression
33%
Tamoxifen
16%
Estrogens
8%
Eicosanoid Receptor
8%
Mitogen-Activated Protein Kinase
8%
Transcriptome
8%
Corepressor
8%
Fulvestrant
8%
Raloxifene
8%
Hormone Receptor
8%
IRF1
8%
Toremifene
8%
Nucleophosmin
8%
X Box Binding Protein 1
8%
Growth Factor
8%
Epileptic Absence
8%